Real-time enrollment status for this high-risk neuroblastoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 1:07 PM UTC
| NCT Number | NCT07549321 |
| Recruiting Status | Recruiting |
| Condition | High-Risk Neuroblastoma |
| Phase | Clinical Trial |
| Target Enrollment | 144 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Renaissance Pharma Ltd. |
| Last Updated on CT.gov | June 30, 2026 (1 week ago) |
As of July 13, 2026: Clinical trial NCT07549321 is currently recruiting participants. This clinical trial study for high-risk neuroblastoma is actively seeking new participants at 5 locations across the United States. The study is sponsored by Renaissance Pharma Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07549321 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07549321 was last updated 1 week ago (June 30, 2026). HelloStudys verifies this status automatically.